[1]JournalofOrganicChemistry,2007,vol.72,p.4149-4155
[1]JournalofOrganicChemistry,2007,vol.72,p.4149-4155
[1]JournalofOrganicChemistry,2007,vol.72,p.4864-4871
[1]JournalofOrganicChemistry,2007,vol.72,p.4149-4155
[2]JournalofOrganicChemistry,2007,vol.72,p.4149-4155
[3]JournalofOrganicChemistry,2007,vol.72,p.4149-4155
[4]JournalofOrganicChemistry,2007,vol.72,p.4149-4155
[1]JournalofOrganicChemistry,2007,vol.72,p.4149-4155
[2]JournalofOrganicChemistry,2007,vol.72,p.4149-4155
[3]JournalofOrganicChemistry,2007,vol.72,p.4149-4155
[4]JournalofOrganicChemistry,2007,vol.72,p.4149-4155
Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.
Journal: Bioorganic & medicinal chemistry letters 20130801
Title: Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110910
Title: Determination of the gamma-secretase inhibitor MK-0752 in human plasma by online extraction and electrospray tandem mass spectrometry (HTLC-ESI-MS/MS).
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100901
Title: Determination of a novel gamma-secretase inhibitor in human plasma and cerebrospinal fluid using automated 96 well solid phase extraction and liquid chromatography/tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080215
Title: Cook JJ, et al. Acute gamma-secretase inhibition of nonhuman primate CNS shifts amyloid precursor protein (APP) metabolism from amyloid-beta production to alternative APP fragments without amyloid-beta rebound. J Neurosci. 2010;30(19):6743-6750.
Title: Krop I, et al. Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors. J Clin Oncol. 2012;30(19):2307-2313.